Home › Companies › Bio-Techne Corporation › 2025-2026

Bio-Techne Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Bio-Techne Corporation’s Form 8-K, filed 2025-11-05 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 14Reported items
  • 611Asset managers
  • 7,646Fund votes
  • 2025-10-30Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Bio-Techne Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Bio-Techne Corporation

These tallies are Bio-Techne Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-11-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Bio-Techne Corporation — official shareholder meeting results, meeting held 2025-10-30
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Proposal 1: The shareholders voted to set the number of directors at nine: 140,278,598314,005234,956 --0 Majority: yes
Elect Director: Robert V. Baumgartner 134,015,6776,570,465241,417 --0 Majority: yes
Elect Director: Julie L. Bushman 136,076,2434,511,497239,819 --0 Majority: yes
Elect Director: John L. Higgins 135,131,2105,460,347236,002 --0 Majority: yes
Elect Director: Kim Kelderman 139,472,8951,087,500267,164 --0 Majority: yes
Elect Director: Joseph D. Keegan 136,272,1534,315,695239,711 --0 Majority: yes
Elect Director: Alpna Seth 134,628,2835,957,489241,787 --0 Majority: yes
Elect Director: Rupert Vessey 137,441,1393,145,646240,774 --0 Majority: yes
Elect Director: Judith Klimovsky 138,104,2992,120,409602,851 --0 Majority: yes
Elect Director: Amy Herr 139,257,9471,323,873245,739 --0 Majority: yes
Proposal 3: The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement: 100,792,82439,025,3211,009,414 --0 Majority: yes
Proposal 4: The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026. 137,578,5593,055,503193,497 --0 Majority: yes

Source: Bio-Techne Corporation, Form 8-K, filed with the SEC on 2025-11-05 — read the filing on EDGAR.

How asset managers voted at the Bio-Techne Corporation 2025-2026 meeting

Each item below shows how the 611 asset managers that disclosed a Bio-Techne Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Bio-Techne Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approve, on an advisory basis, the compensation of our executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%AGAINST 28%
FOR: 100,792,824AGAINST: 39,025,321

Bio-Techne Corporation’s own tally for this item (“Proposal 3: The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 100,792,824 for, 39,025,321 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 63% for, 25% against (88% of the company cast a for/against vote).

The 576 asset managers below cast 73% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 73%AGAINST 27%
FOR: 72.8%AGAINST: 26.7%ABSTAIN: 0.4%NOT VOTED: 0.0%
Largest asset managers voting on “Approve, on an advisory basis, the compensation of our executive officers.” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard20,656,496409,463 00For
BlackRock9,709,518926,215 00For
T. Rowe Price5,931,2532,041,880 00For
Invesco07,369,044 00Against
ATLANTA CAPITAL MANAGEMENT CO L L C5,064,46977,290 00For
GEODE CAPITAL MANAGEMENT, LLC4,215,8700 00For
Neuberger Berman4,215,2980 00For
Eaton Vance3,979,12993,341 00For
Fidelity3,836,26412,106 00For
Wellington3,807,0210 00For
State Street3,231,13389,411 3,5750For
American Century03,182,582 00Against
Charles Schwab3,096,0920 00For
DF DENT & CO INC2,845,1770 00For
MACKENZIE FINANCIAL CORP2,559,5740 00For
BAMCO INC /NY/2,443,2420 00For
RGM Capital, LLC2,300,0520 00For
Select Equity Group, L.P.2,212,8440 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
Amova Asset Management Co., Ltd.01,828,136 00Against
NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST01,815,303 00Against
TRUST FOR PROFESSIONAL MANAGERS1,744,8443,151 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1,632,7600 00For
Capital Group1,576,71366 00For
Capital Research Global Investors1,576,7130 00For

Showing the 25 largest of 576 asset managers. See all 576 in the interactive database.

2. Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 137,578,559AGAINST: 3,055,503

Bio-Techne Corporation’s own tally for this item (“Proposal 4: The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026.”): 137,578,559 for, 3,055,503 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 87% for, 2% against (89% of the company cast a for/against vote).

The 151 asset managers below cast 99.9% of the shares they voted on this item FOR (70,490,345 for, 18,659 against).

FOR 99.9%
FOR: 70,490,345 (100.0%)AGAINST: 18,659 (0.0%)ABSTAIN: 5,000 (0.0%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 202” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,515,1283,191 00For
BlackRock5,496,5510 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,85627 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust959,9370 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 151 asset managers. See all 151 in the interactive database.

3. Elections of Directors: Alpna Seth

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 134,628,283AGAINST: 5,957,489

Bio-Techne Corporation’s own tally for this item (“Elect Director: Alpna Seth”): 134,628,283 for, 5,957,489 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 85% for, 4% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 98% of the shares they voted on this item FOR (69,265,093 for, 1,187,551 against).

FOR 98%
FOR: 69,265,093 (98.3%)AGAINST: 1,187,551 (1.7%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Elections of Directors: Alpna Seth” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,518,3182 00For
BlackRock5,495,572979 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,8830 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust959,9370 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional0541,628 00Against
Hartford528,2480 00For
BNY Mellon57,847455,478 00Against
Lincoln Financial473,0259,074 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

4. Elections of Directors: Amy E. Herr

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 139,257,947AGAINST: 1,323,873

Bio-Techne Corporation’s own tally for this item (“Elect Director: Amy Herr”): 139,257,947 for, 1,323,873 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 88% for, 0.9% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (70,451,664 for, 980 against).

FOR 99.9%
FOR: 70,451,664 (99.9%)AGAINST: 980 (0.0%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Elections of Directors: Amy E. Herr” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,518,3191 00For
BlackRock5,495,572979 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,8830 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust959,9370 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

5. Elections of Directors: John L. Higgins

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 135,131,210AGAINST: 5,460,347

Bio-Techne Corporation’s own tally for this item (“Elect Director: John L. Higgins”): 135,131,210 for, 5,460,347 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 85% for, 3% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 99.7% of the shares they voted on this item FOR (70,283,352 for, 169,292 against).

FOR 99.7%
FOR: 70,283,352 (99.7%)AGAINST: 169,292 (0.2%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Elections of Directors: John L. Higgins” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,518,3182 00For
BlackRock5,495,572979 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,85627 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust811,459148,478 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

6. Elections of Directors: Joseph D. Keegan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 136,272,153AGAINST: 4,315,695

Bio-Techne Corporation’s own tally for this item (“Elect Director: Joseph D. Keegan”): 136,272,153 for, 4,315,695 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 86% for, 3% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (70,449,069 for, 3,575 against).

FOR 99.9%
FOR: 70,449,069 (99.9%)AGAINST: 3,575 (0.0%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Elections of Directors: Joseph D. Keegan” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,518,3182 00For
BlackRock5,495,572979 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,8830 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust959,9370 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

7. Elections of Directors: Judith Klimovsky

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 138,104,299AGAINST: 2,120,409

Bio-Techne Corporation’s own tally for this item (“Elect Director: Judith Klimovsky”): 138,104,299 for, 2,120,409 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 87% for, 1% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (70,449,072 for, 3,572 against).

FOR 99.9%
FOR: 70,449,072 (99.9%)AGAINST: 3,572 (0.0%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Elections of Directors: Judith Klimovsky” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,518,3191 00For
BlackRock5,495,572979 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,8830 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust959,9370 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

8. Elections of Directors: Julie L. Bushman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 136,076,243AGAINST: 4,511,497

Bio-Techne Corporation’s own tally for this item (“Elect Director: Julie L. Bushman”): 136,076,243 for, 4,511,497 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 86% for, 3% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (70,451,661 for, 983 against).

FOR 99.9%
FOR: 70,451,661 (99.9%)AGAINST: 983 (0.0%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Elections of Directors: Julie L. Bushman” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,518,3182 00For
BlackRock5,495,572979 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,8830 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust959,9370 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

9. Elections of Directors: Kim Kelderman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 139,472,895AGAINST: 1,087,500

Bio-Techne Corporation’s own tally for this item (“Elect Director: Kim Kelderman”): 139,472,895 for, 1,087,500 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 88% for, 0.7% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (70,451,664 for, 979 against).

FOR 99.9%
FOR: 70,451,664 (99.9%)AGAINST: 979 (0.0%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Elections of Directors: Kim Kelderman” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,518,3190 00For
BlackRock5,495,572979 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,8830 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust959,9370 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

10. Elections of Directors: Robert V. Baumgartner

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 134,015,677AGAINST: 6,570,465

Bio-Techne Corporation’s own tally for this item (“Elect Director: Robert V. Baumgartner”): 134,015,677 for, 6,570,465 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 84% for, 4% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 99.7% of the shares they voted on this item FOR (70,247,254 for, 205,390 against).

FOR 99.6%
FOR: 70,247,254 (99.7%)AGAINST: 205,390 (0.3%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Elections of Directors: Robert V. Baumgartner” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,515,1273,192 00For
BlackRock5,495,572979 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,85627 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust811,459148,478 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

11. Elections of Directors: Rupert Vessey

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 137,441,139AGAINST: 3,145,646

Bio-Techne Corporation’s own tally for this item (“Elect Director: Rupert Vessey”): 137,441,139 for, 3,145,646 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 87% for, 2% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (70,451,662 for, 982 against).

FOR 99.9%
FOR: 70,451,662 (99.9%)AGAINST: 982 (0.0%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “Elections of Directors: Rupert Vessey” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,518,3191 00For
BlackRock5,495,572979 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,8830 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust959,9370 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

12. To set the number of Directors at nine.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 140,278,598AGAINST: 314,005

Bio-Techne Corporation’s own tally for this item (“Proposal 1: The shareholders voted to set the number of directors at nine:”): 140,278,598 for, 314,005 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 88% for, 0.2% against (88% of the company cast a for/against vote).

The 150 asset managers below cast 100% of the shares they voted on this item FOR (70,452,644 for, 0 against).

FOR 99.9%
FOR: 70,452,644 (99.9%)ABSTAIN: 39,484 (0.1%)NOT VOTED: 121 (0.0%)
Largest asset managers voting on “To set the number of Directors at nine.” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard19,518,3200 00For
BlackRock5,496,5510 00For
Eaton Vance3,979,1290 00For
Fidelity3,822,1990 00For
Invesco3,601,7330 00For
T. Rowe Price3,093,7380 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)2,161,9440 00For
TRUST FOR PROFESSIONAL MANAGERS1,747,9950 00For
Neuberger Berman1,607,4000 00For
State Street1,586,8830 00For
Capital Group1,576,7130 00For
Charles Schwab1,524,0820 00For
American Century1,519,7760 00For
Waddell & Reed1,368,1420 00For
MFS1,216,9740 00For
Columbia Threadneedle1,156,3170 00For
Advisors' Inner Circle Fund II1,082,4400 00For
Bridge Builder Trust959,9370 00For
TIAA903,6060 00For
WEITZ FUNDS802,1500 00For
Legg Mason556,6030 00For
Dimensional541,6280 00For
Hartford528,2480 00For
BNY Mellon513,3250 00For
Lincoln Financial482,0990 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

13. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

72% Majority: yes · of votes cast

FOR 72%AGAINST 28%
FOR: 100,792,824AGAINST: 39,025,321

Bio-Techne Corporation’s own tally for this item (“Proposal 3: The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 100,792,824 for, 39,025,321 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 63% for, 25% against (88% of the company cast a for/against vote).

The 18 asset managers below cast 62% of the shares they voted on this item FOR (833,792 for, 510,314 against).

FOR 62%AGAINST 38%
FOR: 833,792 (62.0%)AGAINST: 510,314 (38.0%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Eversept Partners, LP631,4070 00For
APG Asset Management US Inc.0348,533 00Against
JPMorgan155,3120 00For
Lincoln Financial0116,856 00Against
Metzler Asset Management GmbH31,0910 00For
Empower018,326 00Against
Coyle Financial Counsel LLC15,8810 00For
Dundas Partners LLP09,936 00Against
OSSIAM05,542 00Against
HC CAPITAL TRUST04,564 00Against
Sepio Capital, LP03,111 00Against
CLEARWATER INVESTMENT TRUST02,500 00Against
Union Investment Management GmbH0938 00Against
Convergence Investment Partners, LLC560 00For
Resolute Advisors LLC320 00For
ANDERSON HOAGLAND & CO80 00For
Colony Family Offices, LLC08 00Against
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma50 00For

14. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%AGAINST 28%
FOR: 100,792,824AGAINST: 39,025,321

Bio-Techne Corporation’s own tally for this item (“Proposal 3: The shareholders adopted a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 100,792,824 for, 39,025,321 against, per its Form 8-K filed 2025-11-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,878,127 outstanding shares: 63% for, 25% against (88% of the company cast a for/against vote).

The 8 asset managers below cast 36% of the shares they voted on this item FOR (50,918 for, 92,463 against).

FOR 21%AGAINST 38%ABSTAIN 34%7%
FOR: 50,918 (20.9%)AGAINST: 92,463 (37.9%)ABSTAIN: 82,408 (33.8%)NOT VOTED: 18,000 (7.4%)
Largest asset managers voting on “14A Executive Compensation” at Bio-Techne Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Summit Creek Advisors LLC077,463 00Against
HAHN CAPITAL MANAGEMENT LLC44,9340 00For
MONIMUS CAPITAL MANAGEMENT, LP00 41,4800Abstain
LEAVELL INVESTMENT MANAGEMENT, INC.00 40,9280Abstain
WILLIAMSBURG INVESTMENT TRUST015,000 00Not Voted
Claret Asset Management Corp4,3010 00For
COURIER CAPITAL LLC1,6800 00For
Baker Avenue Asset Management, LP30 00For

Largest Bio-Techne Corporation shareholders voting in 2025-2026

Ranked by the number of Bio-Techne Corporation shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 158,878,127 shares outstanding at the time of that meeting.

Top Bio-Techne Corporation shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 13.26%
2BlackRock 6.69%
3T. Rowe Price 5.02%
4Invesco 4.64%
5ATLANTA CAPITAL MANAGEMENT CO L L C 3.24%
6GEODE CAPITAL MANAGEMENT, LLC 2.65%
7Neuberger Berman 2.65%
8Eaton Vance 2.56%
9Fidelity 2.42%
10Wellington 2.40%

Reported Bio-Techne Corporation ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Bio-Techne Corporation beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Malvern, PA 11.58% DEF14A
BlackRock 7.72% 13F
New York, NY 7.53% DEF14A
Baltimore, MD 6.40% DEF14A
Morgan Stanley 5.25% 13F
FMR (Fidelity) 4.97% 13F
State Street 3.69% 13F
Wellington Management 3.22% 13F
Invesco 2.89% 13F
T. Rowe Price 1.54% 13F

Percentages above are of 158,878,127 shares outstanding, as reported by Bio-Techne Corporation on its Form 10-Q dated 2024-09-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Bio-Techne Corporation’s 10-Q dated 2024-09-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Bio-Techne Corporation's shareholder meeting held 2025-10-30, in the 2025-2026 proxy season, 611 asset managers reported how they voted in their SEC Form N-PX filings, covering 7,646 separate fund positions. Their filings are grouped here into 14 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approve, on an advisory basis, the compensation of our executive officers. — FOR was 72% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Bio-Techne Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-11-05.

Bio-Techne Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).